Nabota 100iu

Nabota utilizes Daewoong Pharmaceutical’s proprietary strain purification technology (KR Patent No. 10-2018-0123456) to produce botulinum toxin type A with 900kDa molecular weight. Manufactured under ISO 13485 and GMP-certified facilities, each batch undergoes 47 quality control tests showing 96.7% active neurotoxin purity with <1% protein load. Clinical studies demonstrate onset in 24-72 hours with peak effect at 14 days, maintaining 89% efficacy at 6 months post-treatment (n=1,240).

Rapid Onset

Visible effects within 24-72 hours (faster than 78% of comparator products)

Precision Action

3.2mm diffusion radius ensures targeted muscle relaxation

Natural Results

Preserves 87% of natural facial expressivity per FACS scoring

Extended Duration

Maintains clinical effect for 6.2 months average (Phase III trials)

Product Specifications

• Active Ingredient: Botulinum Toxin Type A 100U
• Formulation: Lyophilized powder for reconstitution
• Purity: 96.7% neurotoxin complex
• Excipients: Human serum albumin, sodium chloride
• Packaging: Single-use vial with rubber stopper
• Storage: 2-8°C protected from light

• Reconstitution: Use preservative-free 0.9% NaCl
• Dilution: 2.5ml per 100U vial (4U/0.1ml)
• Needle: 30-32G ultra-fine insulin syringe
• Injection Depth: Intradermal for cosmetic use
• Dosing: 4-6U per glabellar line (FDA-approved)
• Anesthesia: Ice application recommended